Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit.
Behrouz MollashahiHamid Latifi-NavidIman OwliaeeSara ShamdaniGeorges UzanSaleh JamehdorSina NaserianPublished in: Molecules (Basel, Switzerland) (2023)
The most widely used genome editing toolkit is CRISPR (clustered regularly interspaced short palindromic repeats). It provides the possibility of replacing and modifying DNA and RNA nucleotides. Furthermore, with advancements in biological technology, inhibition and activation of the transcription of specific gene(s) has become possible. Bioinformatics tools that target the evolution of CRISPR-associated protein 9 (Cas9) turn this protein into a vehicle that is specific for a DNA or RNA region with single guide RNA (sgRNA). This toolkit could be used by researchers to investigate the function of stem cell gene(s). Here, in this review article, we cover recent developments and applications of this technique in stem cells for research and clinical purposes and discuss different CRISPR/Cas technologies for knock-out, knock-in, activation, or inhibition of gene expression. Additionally, a comparison of several deliveries and off-target detecting strategies is discussed.
Keyphrases
- genome editing
- stem cells
- crispr cas
- gene expression
- nucleic acid
- genome wide
- copy number
- cell therapy
- dna methylation
- genome wide identification
- transcription factor
- circulating tumor
- single molecule
- cell free
- sensitive detection
- fluorescent probe
- bone marrow
- protein protein
- living cells
- genome wide analysis
- circulating tumor cells